Dr Reddys Laboratories Ltd reports Rs. 1392 crores consolidated PAT in Q1FY25

Dr. Reddy's Laboratories Limited has reported Consolidated financial results for the period ended June 30, 2024.

Financial Results (Q1 FY2025) - QoQ Comparison

The company has reported total income of Rs. 7672.7 crores during the period ended June 30, 2024 as compared to Rs. 7083 crores during the period ended March 31, 2024.

The company has posted net profit / (loss) of Rs. 1392 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs. 1307 crores for the period ended March 31, 2024.

The company has reported EPS of Rs. 83.46 for the period ended June 30, 2024 as compared to Rs. 78.35 for the period ended March 31, 2024.

Financials	Q1 FY2025	Q4 FY2024	% Change
Total Income	₹ 7672.7 crs	₹7083 crs	8.33%
Net Profit	₹1392 crs	₹1307 crs	6.50%
EPS	₹83.46	₹78.35	6.52%

Financial Results (Q1 FY2025) - YoY Comparison

The company has reported total income of Rs. 7672.7 crores during the period ended June 30, 2024 as compared to Rs.6738.4 crores during the period ended June 30, 2023.

The company has posted net profit / (loss) of Rs.1392 crores for the period ended June 30, 2024 as against net profit / (loss) of Rs.1402.5 crores for the period ended June 30, 2023.

The company has reported EPS of Rs.83.46 for the period ended June 30, 2024 as compared to Rs.84.22 for the period ended June 30, 2023.

Financials	Q1 FY2025	Q1 FY2024	% Change
Total Income	₹ 7672.7 crs	₹6738.4 crs	13.87%
Net Profit	₹1392 crs	₹1402.5 crs	-0.75%
EPS	₹83.46	₹84.22	-0.90%

Shares of Dr. Reddy's Laboratories Limited was last trading in BSE at Rs. 6892.15 as compared to the previous close of Rs. 6854.20. The total number of shares traded during the day was 11887 in over 2838 trades.

The stock hit an intraday high of Rs. 6960.00 and intraday low of 6795.40. The net turnover during the day was Rs. 81550591.00.

Source : Equity Bulls

Keywords

DrReddysLaboratories Q1FY25 FY2025 Q1FY2025 ResultUpdate RDY